VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SLSSELLAS Life Sciences Group, Inc.
$15.45$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSLSQuarterly Financials

SELLAS Life Sciences Group, Inc. (SLS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

SELLAS Life Sciences Group, Inc. (SLS) quarterly income statement — complete revenue, gross profit & net income history

SLS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000001M001.9M
Revenue Growth %-------------100%---100%-82.46%-100%--
Cost of Goods Sold0000000000000123K00145K1.27M0100K
COGS % of Revenue----------------14.5%--5.26%
Gross Profit0000000000000-123K00855K-1.27M01.8M
Gross Margin %----------------85.5%--94.74%
Gross Profit Growth %---------100%---100%90.34%--100%-84.73%-167%--
Operating Expenses9.25M8.26M7.08M6.87M6.06M6.92M7.33M7.62M9.64M8.18M9.36M9.05M11.28M9.32M7.15M8.62M7.59M4.65M6.98M6.25M
OpEx % of Revenue----------------759%--329.11%
Selling, General & Admin4.12M3.52M2.87M3M2.86M2.48M2.97M2.44M4.53M3.08M3.55M3.13M4.11M3.48M2.86M3.09M2.98M1.25M2.44M2.8M
SG&A % of Revenue----------------297.9%--147.21%
Research & Development5.13M4.73M4.22M3.87M3.21M4.44M4.36M5.19M5.11M5.1M5.81M5.92M7.17M5.85M4.28M5.53M4.61M3.39M4.54M3.46M
R&D % of Revenue----------------461.1%--181.89%
Other Operating Expenses00000000000000000000
Operating Income-9.25M-8.26M-7.08M-6.87M-6.06M-6.92M-7.33M-7.62M-9.64M-8.18M-9.36M-9.05M-11.28M-9.45M-7.15M-8.62M-6.74M-5.92M-6.98M-4.45M
Operating Margin %-----------------673.5%---234.37%
Operating Income Growth %-52.6%-19.33%3.36%9.81%37.14%15.4%21.71%15.79%14.5%13.43%-31%-4.95%-67.5%-59.59%-2.42%-93.64%-200%-42.32%-55.32%-4.36%
EBITDA-9.25M-8.26M0-6.6M-6.06M-16.56M-7.33M-7.62M-9.64M-8.14M-9.27M-9.05M-11.28M-9.32M-7.15M-8.62M-6.69M-4.65M-6.98M-4.45M
EBITDA Margin %-----------------669%---234.37%
EBITDA Growth %-52.6%50.16%100%13.38%37.14%-103.58%20.91%15.79%14.5%12.73%-29.68%-4.95%-68.62%-100.67%-2.42%-93.64%-198%--55.32%-4.36%
D&A (Non-Cash Add-back)007.08M00-9.64M0000000123K0045K1.27M00
EBIT-9.25M-8.26M-6.79M-6.6M-6.06M-6.74M-7.33M-7.62M-9.64M-8.14M-9.27M-9.05M-11.28M-9.12M-7.15M-8.62M-16.74M-6.83M-6.98M-4.45M
Net Interest Income845K597K292K272K250K181K221K151K79K41K94K208K182K158K111K46K2K02K2K
Interest Income845K597K292K272K250K181K221K151K79K41K94K208K182K158K111K46K2K02K2K
Interest Expense00000000000000000000
Other Income/Expense845K597K292K272K250K181K221K151K79K41K94K210K184K325K124K209K-10.01M-916K-108K-160K
Pretax Income-8.41M-7.66M-6.79M-6.6M-5.81M-6.74M-7.11M-7.47M-9.57M-8.14M-9.27M-8.84M-11.1M-9.12M-7.02M-8.41M-16.74M-6.83M-7.08M-4.61M
Pretax Margin %-----------------1674.4%---242.79%
Income Tax00000000000000000-237K00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%3.47%0%0%
Net Income-8.41M-7.66M-6.79M-6.6M-5.81M-6.74M-7.11M-7.47M-9.57M-8.14M-9.27M-8.84M-11.1M-9.12M-7.02M-8.41M-16.74M-6.6M-7.08M-4.61M
Net Margin %-----------------1674.4%---242.79%
Net Income Growth %-44.62%-13.67%4.46%11.63%39.23%17.2%23.3%15.5%13.8%10.8%-31.97%-5.06%33.73%-38.24%0.89%-82.4%-596.8%-77.56%-58.39%-4.25%
Net Income (Continuing)-8.41M-7.66M-6.79M-6.6M-5.81M-6.74M-7.11M-7.47M-9.57M-8.14M-9.27M-8.84M-11.1M-9.12M-7.02M-8.41M-16.74M-6.6M-7.08M-4.61M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.05-0.05-0.06-0.07-0.07-0.09-0.10-0.13-0.21-0.26-0.33-0.31-0.47-0.44-0.34-0.41-1.05-0.42-0.45-0.30
EPS Growth %26.43%45.12%37.4%46.15%68.48%64.96%69.7%58.06%55.32%40.91%2.94%24.39%55.24%-4.76%24.44%-36.67%-556.25%-16.67%15.09%54.55%
EPS (Basic)-0.05-0.05-0.06-0.07-0.07-0.09-0.10-0.13-0.21-0.26-0.33-0.31-0.47-0.44-0.34-0.41-1.05-0.42-0.45-0.30
Diluted Shares Outstanding172.48M153.1M108.4M98.56M87.76M73.99M68.25M57.63M44.81M30.8M28.36M28.35M23.55M20.79M20.56M20.29M15.9M15.89M15.87M15.27M
Basic Shares Outstanding172.48M153.1M108.4M94.3M87.76M73.99M68.25M57.46M44.81M30.8M28.36M28.35M23.55M20.79M20.56M20.29M15.9M15.89M15.87M15.27M
Dividend Payout Ratio--------------------